HROW Harrow Health, Inc.

Harrow Health, Inc. (formerly Imprimis Pharmaceuticals Inc) is engaged in the development, production and sale of medications that offer competitive advantages and serve unmet needs. The company intends to deliver high-quality medications to physicians and patients.

$9.27  -0.08 (-0.86%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2019
Outstanding shares:  26,893,896
Average volume:  114,373
Market cap:   $251,457,928
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    415858109
ISIN:        US4158581094
Sedol:      
Valuation   (See tab for details)
PE ratio:   -25.26
PB ratio:   15.09
PS ratio:   3.76
Return on equity:   -56.91%
Net income %:   -14.11%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy